STML

Stemline Therapeutics, Inc.
STML

Delisted

STML was delisted on the 9th of June, 2020.

99 hedge funds and large institutions have $449M invested in Stemline Therapeutics, Inc. in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 46 increasing their positions, 20 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
99
Holders Change
-1
Holders Change %
-1%
% of All Funds
1.95%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
17
Increased
46
Reduced
20
Closed
18
Calls
$314K
Puts
$631K
Net Calls
-$317K
Net Calls Change
+$323K
Name Holding Trade Value Shares
Change
Shares
Change %
Point72 Asset Management
101
Point72 Asset Management
Connecticut
-$2.26M -217,500 Closed
T. Rowe Price Associates
102
T. Rowe Price Associates
Maryland
-$1.84M -176,795 Closed
PVI
103
Pura Vida Investments
New York
-$1.38M -132,422 Closed
LCM
104
Laurion Capital Management
New York
-$1.04M -100,000 Closed
BFM
105
Boothbay Fund Management
New York
-$959K -92,152 Closed
OAM
106
Oxford Asset Management
United Kingdom
-$597K -57,346 Closed
Neuberger Berman Group
107
Neuberger Berman Group
New York
-$585K -56,228 Closed
GCP
108
GSA Capital Partners
United Kingdom
-$479K -46,033 Closed
Squarepoint
109
Squarepoint
New York
-$479K -45,981 Closed
Verition Fund Management
110
Verition Fund Management
Connecticut
-$364K -35,000 Closed
BG
111
Bellevue Group
Switzerland
-$328K -31,500 Closed
Simplex Trading
112
Simplex Trading
Illinois
-$170K -16,334 Closed
WG
113
Winton Group
United Kingdom
-$105K -10,071 Closed
MWNA
114
Marshall Wace North America
New York
-$96K -9,223 Closed
TRCT
115
Tower Research Capital (TRC)
New York
-$74K -7,115 Closed
Marshall Wace
116
Marshall Wace
United Kingdom
-$35K -3,354 Closed